Drug-induced altered self-presentation increases tumor immunogenicity
Author:
Funder
Japan Foundation New York
Takeda Science Foundation
Institute of Natural Medicine, University of Toyama
Tamura Science and Technology Foundation
Japan Society for the Promotion of Science
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference43 articles.
1. Discovery strategies to maximize the clinical potential of t-cell engaging antibodies for the treatment of solid tumors;Voynov;Antibodies,2020
2. Checkpoint inhibitor immunotherapy in kidney cancer;Xu;Nat. Rev. Urol.,2020
3. Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy;Rotte;Ann. Oncol.,2018
4. Exposing hidden targets: combining epigenetic and immunotherapy to overcome cancer resistance;Olino;Semin Cancer Biol.,2020
5. High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors;Maleki Vareki;J. Immunother. Cancer,2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3